(CRTX) |
| 0 (0%) 01-13 23:41 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 2.30 |
| Resistance 1: | 1.97 |
| Pivot price: | 1.95 |
| Support 1: | 1.90 |
| Support 2: | 1.86 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -2.963 |
| Book Value | 3.530 |
| PEG Ratio | -0.04 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -37.5 |
| Return on Equity (ttm) | -67.3 |
Company news
Thu, 08 Jan 2026
CRISM Therapeutics Reveals Updated Major Shareholders After December Fundraising - TipRanks
Wed, 10 Dec 2025
CRISM Therapeutics launches retail offer to raise up to £100,000 - Investing.com
Wed, 10 Dec 2025
CRISM Therapeutics Launches £100,000 Retail Offer to Fund Clinical Trial - TipRanks
Tue, 14 Oct 2025
RNS Hotlist with Zak Mir: OBD, CRTX, ECOB, EEE, MAST, COBR, MIRI, G4M, ROAD & HODL - Share Talk
Mon, 15 Sep 2025
AIM Market Roundup: Renalytix, Sunrise Resources, Crism Therapeutics - The Armchair Trader
Wed, 27 Oct 2021
Here's Why Cortexyme Is Imploding on Wednesday - The Motley Fool
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
